Non-Tuberculous Mycobacteria (NTM) are ubiquitous in nature, present in soil and water, and cause primary leading to disseminated infections in immunocompromised individuals. NTM infections are surging in recent years due to an increase in an immune-suppressed population, medical interventions, and patients with underlying lung diseases. Host regulators of innate immune responses, frontiers for controlling infections and dissemination, are poorly defined during NTM infections. Here, we describe the role of CBLB, an E3-ubiquitin ligase, for innate immune responses and disease progression in a mouse model of NTM infection under compromised T-cell immunity. We found that CBLB thwarted NTM growth and dissemination in a time- and infection route- dependent manner. Mechanistically, we uncovered defects in many innate immune cells in the absence of Cblb , including poor responses of NK cells, inflammatory monocytes, and conventional dendritic cells. Strikingly, Cblb-deficient macrophages were competent to control NTM growth in vitro . Histopathology suggested the lack of early formation of granulomatous inflammation in the absence of CBLB. Collectively, CBLB is essential to mount productive innate immune responses and help prevent the dissemination during an NTM infection under T-cell deficiency.
Pyocyanin is a potent redox-cycling secondary metabolite secreted by the respiratory pathogen Pseudomonas aeruginosa. During chronic P. aeruginosa infections, pyocyanin induces persistent oxidative stress in airway epithelial cells, ultimately leading to goblet cell hyperplasia and metaplasia alongside mucus hypersecretion. Because PCN triggers a redox imbalance by rapid depletion of host antioxidants, restoring cellular antioxidative capacity is essential to mitigate its pathophysiology. Herein, we demonstrate that Coenzyme Q9 (CoQ9) from the edible mushroom Oudemansiella raphanipes attenuates pyocyanin-induced mucus hypersecretion in primary human bronchial epithelial cells by restoring mitochondrial integrity to alleviate oxidative stress. CoQ9 pretreatment attenuates MUC5AC and MUC5B mucin expression by inactivating mucin-promoting signaling cascades, including the EGFR-AKT/ERK1/2 and STAT6-SPDEF axes. In addition to its reactive oxygen species scavenging properties, CoQ9 significantly downregulated pyocyanin-induced mitochondrial superoxide generation by restoring the SIRT3-SOD2 axis. Specifically, CoQ9 pretreatment improved mitochondrial integrity by preserving PINK1-mediated mitophagy and enhancing mitochondrial biogenesis through activation of the AMPK-PGC1α axis, thereby restoring ATP levels under PCN exposure.
The potent redox-cycling Pseudomonas aeruginosa secondary metabolite pyocyanin induces acute and persistent oxidative stress in diseased airways. Pyocyanin promotes goblet cell hyperplasia and metaplasia and exacerbates the mucus burden. Forkhead Box A2 (FOXA2) is a key pioneer factor that governs the transition of airway basal epithelial and club cells to goblet cells by transcriptionally repressing the expression of MUC5AC and MUC5B mucin genes. FOXA2 activity is negatively regulated by Thr156 phosphorylation in various cell types. However, how post-translational modifications modulate the transcriptional repression of FOXA2 on airway mucin genes remains uncharacterized. Here, we demonstrate that the interaction between SIRT1 and FOXA2 is significantly increased within pyocyanin-exposed MUC5AC-expressing human bronchial epithelial cells, and in human COPD and pyocyanin-exposed mouse lungs. Pyocyanin promotes SIRT1-mediated deacetylation of FOXA2, which serves as a prerequisite for subsequent phosphorylation, inactivation, and MUC5AC derepression. Specifically, under pyocyanin-imposed oxidative stress, SIRT1 deacetylates FOXA2 at Lys259, which dictates phosphorylation at Thr156, leading to nuclear exclusion, ubiquitination, and proteasome-mediated degradation, initiating airway goblet cell transdifferentiation. By contrast, inactivation of SIRT1 by transient knockdown and chemical inhibition impedes pyocyanin-induced FOXA2 phosphorylation and MUC5AC expression. Our results uncover a novel role of SIRT1 in regulating FOXA2 expression dynamics governing airway mucus homeostasis.